Genetic research on MASLD: New insights into cardiovascular disease and cancer risk.
作者信息
Yang Ming, Liu Juan
机构信息
Hepato-Pancreato-Biliary Center, Beijing Tsinghua Changgung Hospital, Key Laboratory of Digital Intelligence Hepatology (Ministry of Education/Beijing), School of Clinical Medicine, Tsinghua University, Beijing 102218, China.
出版信息
ILIVER. 2024 Aug 10;3(3):100108. doi: 10.1016/j.iliver.2024.100108. eCollection 2024 Sep.
Abstract
摘要
相似文献
1
Genetic research on MASLD: New insights into cardiovascular disease and cancer risk.非酒精性脂肪性肝病的遗传学研究：对心血管疾病和癌症风险的新见解。
ILIVER. 2024 Aug 10;3(3):100108. doi: 10.1016/j.iliver.2024.100108. eCollection 2024 Sep.
2
Alisol B ameliorated metabolic dysfunction-associated steatotic liver disease via regulating purine metabolism and restoring the gut microbiota disorders.泽泻醇B通过调节嘌呤代谢和恢复肠道微生物群紊乱改善代谢功能障碍相关脂肪性肝病。
Phytomedicine. 2025 Jun 22;145:156992. doi: 10.1016/j.phymed.2025.156992.
3
Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis.代谢功能障碍相关脂肪性肝病与心房颤动：发病机制综述
World J Cardiol. 2025 Jun 26;17(6):106147. doi: 10.4330/wjc.v17.i6.106147.
4
Modeling the health and economic impact of pharmacologic therapies for MASLD in the United States.模拟美国药物治疗非酒精性脂肪性肝炎相关肝病的健康和经济影响。
J Hepatol. 2025 Jan 18. doi: 10.1016/j.jhep.2025.01.009.
5
Associations between MASLD phenotypes and the risk of carotid artery plaque: a cross-sectional study among railway workers.代谢功能障碍相关脂肪性肝病（MASLD）表型与颈动脉斑块风险之间的关联：一项铁路工人的横断面研究
Acta Diabetol. 2025 Jun 24. doi: 10.1007/s00592-025-02536-w.
6
Hemostatic alterations in metabolic dysfunction-associated steatotic liver disease (MASLD) and their link to venous thromboembolism (VTE).代谢功能障碍相关脂肪性肝病（MASLD）中的止血改变及其与静脉血栓栓塞（VTE）的联系。
Thromb Res. 2025 Sep;253:109395. doi: 10.1016/j.thromres.2025.109395. Epub 2025 Jul 6.
7
GCKR Polymorphisms Increase the Risks of Low Bone Mineral Density in Young and Non-Obese Patients With MASLD and Hyperuricemia.GCKR基因多态性增加了患有代谢相关脂肪性肝病和高尿酸血症的年轻非肥胖患者低骨密度的风险。
Kaohsiung J Med Sci. 2025 Jun;41(6):e70017. doi: 10.1002/kjm2.70017. Epub 2025 Apr 9.
8
Association of uric acid levels with the development of metabolic dysfunction-associated and metabolic and alcohol-related/associated steatotic liver disease: a study on Japanese participants undergoing health checkups.尿酸水平与代谢功能障碍相关及代谢和酒精相关/伴发的脂肪性肝病发生的关联：一项针对接受健康检查的日本参与者的研究
Endocr J. 2025 Jun 2;72(6):671-687. doi: 10.1507/endocrj.EJ24-0622. Epub 2025 Feb 26.
9
Metabolic dysfunction-associated steatotic liver disease and sex-specific risk of fatal and non-fatal cardiovascular events: A meta-analysis.代谢功能障碍相关脂肪性肝病与致命和非致命心血管事件的性别特异性风险：一项荟萃分析。
Diabetes Obes Metab. 2025 Sep;27(9):5171-5181. doi: 10.1111/dom.16568. Epub 2025 Jun 25.
10
Extrahepatic Events in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and the Impact of Genetics and Alcohol Intake.代谢功能障碍相关脂肪性肝病患者的肝外事件以及遗传因素和酒精摄入的影响
Hepatol Res. 2025 Jul 1. doi: 10.1111/hepr.14233.
本文引用的文献
1
Differing genetic variants associated with liver fat and their contrasting relationships with cardiovascular diseases and cancer.与肝脂肪相关的不同遗传变异及其与心血管疾病和癌症的相反关系。
J Hepatol. 2024 Dec;81(6):921-929. doi: 10.1016/j.jhep.2024.06.030. Epub 2024 Jul 1.
2
Implications of the evolving knowledge of the genetic architecture of MASLD.代谢相关脂肪性肝病（MASLD）遗传结构不断演变的知识所带来的影响。
Nat Rev Gastroenterol Hepatol. 2024 Jan;21(1):5-6. doi: 10.1038/s41575-023-00866-0.
3
Unraveling the pathogenesis of non-alcoholic fatty liver diseases through genome-wide association studies.通过全基因组关联研究揭示非酒精性脂肪性肝病的发病机制。
J Gastroenterol Hepatol. 2023 Nov;38(11):1877-1885. doi: 10.1111/jgh.16330. Epub 2023 Aug 17.
4
Dissecting causal relationships between nonalcoholic fatty liver disease proxied by chronically elevated alanine transaminase levels and 34 extrahepatic diseases.剖析以慢性升高的丙氨酸转氨酶水平为代表的非酒精性脂肪性肝病与34种肝外疾病之间的因果关系。
Metabolism. 2022 Oct;135:155270. doi: 10.1016/j.metabol.2022.155270. Epub 2022 Jul 29.
5
Associations of muscle mass and grip strength with severe NAFLD: A prospective study of 333,295 UK Biobank participants.肌肉质量和握力与严重非酒精性脂肪性肝病的相关性：英国生物库 333295 名参与者的前瞻性研究。
J Hepatol. 2022 May;76(5):1021-1029. doi: 10.1016/j.jhep.2022.01.010. Epub 2022 Jan 24.
6
The Health Impact of MAFLD, a Novel Disease Cluster of NAFLD, Is Amplified by the Integrated Effect of Fatty Liver Disease-Related Genetic Variants.MAFLD 对健康的影响，一种新型的非酒精性脂肪性肝病疾病群，通过与脂肪性肝病相关的遗传变异的综合效应而放大。
Clin Gastroenterol Hepatol. 2022 Apr;20(4):e855-e875. doi: 10.1016/j.cgh.2020.12.033. Epub 2020 Dec 30.
7
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores.利用多基因风险评分对非酒精性脂肪性肝病进行肝细胞癌风险的无创分层。
J Hepatol. 2021 Apr;74(4):775-782. doi: 10.1016/j.jhep.2020.11.024. Epub 2020 Nov 25.
8
Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping.非酒精性脂肪性肝病、2 型糖尿病和肥胖之间的因果关系对疾病亚表型有影响。
J Hepatol. 2020 Aug;73(2):263-276. doi: 10.1016/j.jhep.2020.03.006. Epub 2020 Mar 10.
Zotero 插件